Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Capital Work in Progress

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Capital Work in Progress ₹143 Cr₹186 Cr₹121 Cr₹65 Cr

What is the latest Capital Work in Progress ratio of CORONA REMEDIES ?

The latest Capital Work in Progress ratio of CORONA REMEDIES is ₹143 Cr based on Mar2026 Consolidated results.
Year Capital Work in Progress
Mar2026₹143 Cr
Mar2025₹186 Cr
Mar2024₹121 Cr
Mar2023₹65 Cr

How is Capital Work in Progress of CORONA REMEDIES Trending?

Years Capital Work in Progress % Change
Mar2026 ₹143 Cr
-23.03
Mar2025 ₹186 Cr
54.20
Mar2024 ₹121 Cr
86.35
Mar2023 ₹65 Cr -

Compare Capital Work in Progress of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,464.6 Cr -0.8% -0.7% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,562.0 Cr -3.2% -7.8% 14.1% Stock Analytics
DIVIS LABORATORIES ₹244,572.0 Cr -3.3% -0.2% 63.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹180,871.0 Cr -2.4% -5% 33.6% Stock Analytics
CIPLA ₹107,770.0 Cr -4% -5.6% -10.2% Stock Analytics
DR REDDYS LABORATORIES ₹100,829.0 Cr -1.2% 4.1% -4.2% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-0.8%

-0.7%

NA
SENSEX

-2.1%

-5.9%

-10.8%


You may also like the below Video Courses